Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filings

Filing date Description Form Filing Group Issuer View

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
3,4,5
View HTML

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

424B4
Registration Statements
View HTML

Registration of up to an additional 20% of securities for an offering filed on an F-1

F-1MEF
Registration Statements
View HTML

EFFECT

EFFECT
Other
View HTML

CERTNAS

CERTNAS
Other
View HTML

Copyright Morningstar